Glenmark gets USFDA nod for chest pain tablets News News / News 6 years ago 506 Views comments Glenmark Pharmaceuticals on Monday said its US arm has received final approval from USFDA for its Nitroglycerin sublingual tablets. Read more
News Biocon gets 10 observations from US FDA for manufacturing lapses at Benguluru unit News / News - 6 years ago
Comments